Citation Impact
Citing Papers
Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody
2016 Standout
ICOS Promotes the Function of CD4+ Effector T Cells during Anti-OX40–Mediated Tumor Rejection
2016 StandoutNobel
Immunotherapy of melanoma
2013
Breast cancer
2019 Standout
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Delivering safer immunotherapies for cancer
2017
Radiotherapy for renal-cell carcinoma
2014
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Mouse models of hepatocellular carcinoma: an overview and highlights for immunotherapy research
2018
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Lymphopenia Association With Gross Tumor Volume and Lung V5 and Its Effects on Non-Small Cell Lung Cancer Patient Outcomes
2014
Current Clinical Trials Testing Combinations of Immunotherapy and Radiation
2014
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
The TNFRs OX40, 4-1BB, and CD40 as targets for cancer immunotherapy
2013
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
1997 Standout
Radiation as an immunological adjuvant: current evidence on dose and fractionation
2012
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
2014 Standout
The confluence of radiotherapy and immunotherapy
2012
Delivery technologies for cancer immunotherapy
2019 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
2017 StandoutNobel
Stereotactic Ablative Radiotherapy for Centrally Located Early Stage Non–Small-Cell Lung Cancer: What We Have Learned
2014
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Current clinical trials testing the combination of immunotherapy with radiotherapy
2016
Pain and Its Treatment in Outpatients with Metastatic Cancer
1994 Standout
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress
1994 Standout
Advancing breast cancer survivorship among African-American women
2015
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
2013 StandoutNobel
The intersection of radiotherapy and immunotherapy: Mechanisms and clinical implications
2016
ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy
2020
Extracranial Oligometastases: A Subset of Metastases Curable With Stereotactic Radiotherapy
2013
Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapy
2016
Combining Radiation and Immunotherapy: A New Systemic Therapy for Solid Tumors?
2014 StandoutNobel
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV + tumors when combined with an E6/E7 peptide vaccine
2015 StandoutNobel
The future of immune checkpoint therapy
2015 StandoutScienceNobel
Radiotherapy combination opportunities leveraging immunity for the next oncology practice
2016
New Paradigms and Future Challenges in Radiation Oncology: An Update of Biological Targets and Technology
2013
Emerging Opportunities and Challenges in Cancer Immunotherapy
2016
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Strategies for Combining Immunotherapy with Radiation for Anticancer Therapy
2015 StandoutNobel
Combination therapy strategies for improving PD‐1 blockade efficacy: a new era in cancer immunotherapy
2017 StandoutNobel
A Systemic Complete Response of Metastatic Melanoma to Local Radiation and Immunotherapy
2012
Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
2014 Standout
The memorial pain assessment card. A valid instrument for the evaluation of cancer pain
1987
Works of Roxanne Payne being referenced
Advances in the management of cancer pain.
1984
Durable responses and reversible toxicity of high-dose interleukin-2 treatment of melanoma and renal cancer in a Community Hospital Biotherapy Program
2014
Phase 1 Study of Stereotactic Body Radiotherapy and Interleukin-2—Tumor and Immunological Responses
2012
Survivorship care plans: Is there buy‐in from community oncology providers?
2013